Quit and Screen Project
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-85
SponsorUniversity of Arkansas
About this trial
The Quit and Screen Project seeks to engage healthcare providers in helping adults who smoke to quit tobacco use, including menthol cigarettes and flavored cigars, and screen for lung cancer early as strategies to reduce multiple chronic diseases.
The goal of this clinical trial is to test the feasibility and impact of the Quit and Screen Project alone versus the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training + the Quit and Screen Project training modules on changes in provider knowledge, attitudes, and behavioral intentions related to provider advice to quit smoking and referrals for low dose computed tomography among health care providers randomly assigned to each condition. Participants will complete the training modules and complete pre- and post-tests to assess these outcomes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Current National Medical Association (NMA) member
Serves a patient clientele who smokes
At least 20% of time (1 day per week) devoted to clinical care
Currently screens clients for tobacco use in the clinic
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Quit and Screen Project training
Other interventionThis online course will be developed for healthcare providers and will fill gaps in knowledge and attitudes toward lung cancer screening and smoking not covered by the G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training.
G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training
Other interventionThe G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training is an online course that covers disparities in lung cancer and smoking, patient barriers to lung cancer screening, and provider resources for addressing common barriers.
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: Quit and Screen Project training aloneExperimental treatment 1 intervention
Group B: Quit and Screen Project training + G02 Lung Cancer Screening trainingExperimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
Familiarity with treatment guidelines for tobacco and nicotine treatment
Familiarity with treatment guidelines was assessed using an modified question from the Healthcare Provider Survey published by Primary Care Development Corporation in 2008.
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.2
Weaver et al. 2012 Provider Attitudes and Perceptions about smoking cessation
These questions assessed providers perceptions about the benefits of smoking cessation and the benefits of providers advising patients to quit smoking.
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.3
Weaver et al. 2012 Provider Perceptions about provider barriers to providing smoking cessation interventions to patients
Perceptions about provider barriers to addressing smoking cessation with patient were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.4
Provider Perceptions about patient barriers to smoking cessation
Perceptions about patient barriers to smoking cessation were assessed using modified questions from a questions published in Weaver et al. 2012, Carter-Harris et al. (2017), and Raz et al. 2019.
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.Secondary outcomes
1
Characteristics of enrolled healthcare providers
Study process tracking metrics will be used to assess the demographic, training, and clinical practice characteristics of providers who enroll in the training.
Time frame
This is pre-post design. This outcome will be measured during the pre-test immediately before participants complete the 30-60 minute online training.2
Retention: Percent of providers complete the training after enrolling
Study process tracking metrics will be used to assess retention of providers who enroll in the training.
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.3
Adherence to completing training modules: Percent of modules completed
Study process tracking metrics and training completion data will be used to assess the percent of training modules completed (i.e., the number of modules completed divided by the total available modules).
Time frame
This is pre-post design where participants will complete a pre-test immediately before completing a 30-60 minute online training and then a post-test immediately after completing training.4
Preferences regarding training
Questions will assess provider feedback on the online training module.
Time frame
This is pre-post design. This outcome will be measured during the post-test immediately after they complete the 30-60 minute online training.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Arkansas
Lead sponsor
Virginia Commonwealth University
Collaborator
Coalition for a Tobacco Free Arkansas
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
National Medical Association
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: